Epilepsy
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Mutations in TBC1D24 are described in patients with a spectrum of neurological diseases, including mild and severe epilepsies and complex syndromic phenotypes such as Deafness, Onycodystrophy, Osteodystrophy, Mental Retardation and Seizure (DOORS) syndrome.
|
30858606 |
2019 |
Epilepsy
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Epilepsy patients identified with TBC1D24 compound heterozygous mutations by next-generation sequencing (NGS) epilepsy panel or whole exome sequencing (WES) were enrolled.
|
31112829 |
2019 |
Epilepsy
|
0.100 |
Biomarker
|
disease |
BEFREE |
TBC1D24-TLDc-related epilepsy exercise-induced dystonia: rescue by antioxidants in a disease model.
|
31257402 |
2019 |
Epilepsy
|
0.100 |
Biomarker
|
disease |
BEFREE |
The delineation of the phenotypic spectrum associated with mutations in ATP1A3, FOXG1, GNAO1, GRIN1, FRRS1L, and TBC1D24 is revealing an expanding genetic overlap between epileptic encephalopathies, developmental delay/intellectual disability, and hyperkinetic movement disorders,.
|
29086067 |
2017 |
Epilepsy
|
0.100 |
Biomarker
|
disease |
BEFREE |
Furthermore, with an increasing number of pathogenic mutations leading to epilepsy and hearing loss being discovered in the TLDc protein TBC1D24, understanding the function of this family has important implications for a range of inherited neurological diseases.
|
28707022 |
2017 |
Epilepsy
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
At present, it is unknown how different mutations of TBC1D24 cause non-syndromic deafness (DFNB86, OMIM 614617), epilepsy (OMIM 605021), epilepsy with deafness, or DOORS syndrome (OMIM 220500) that is characterized by deafness, onychodystrophy (alteration of toenail or fingernail morphology), osteodystrophy (defective development of bone), mental retardation, and seizures.
|
27259978 |
2017 |
Epilepsy
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Mutations in TBC1D24 cause severe epilepsy and DOORS syndrome, but the molecular mechanisms underlying these pathologies are unresolved.
|
27669036 |
2016 |
Epilepsy
|
0.100 |
Biomarker
|
disease |
BEFREE |
Electroclinical phenotypes and outcomes in TBC1D24-related epilepsy.
|
27502353 |
2016 |
Epilepsy
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Given the phenotypic breadth observed, TBC1D24 mutation screening is indicated in a wide variety of epilepsies.
|
27281533 |
2016 |
Epilepsy
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
More recently, TBC1D24 mutations have been shown to cause a variable range of disorders, including epilepsy of various seizure types and severity, non-syndromic deafness, and DOORS syndrome.
|
25769375 |
2015 |
Epilepsy
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Previously, six recessive mutations in TBC1D24 were reported to cause seizures (hearing loss was not reported) ranging in severity from epilepsy with otherwise normal development to epileptic encephalopathy resulting in childhood death.
|
24387994 |
2014 |
Epilepsy
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
TBC1D24 loss of function has been associated to idiopathic infantile myoclonic epilepsy, as well as to drug-resistant early-onset epilepsy with intellectual disability.
|
23526554 |
2013 |